Please provide your email address to receive an email when new articles are posted on . The temporal change rate of proton density fat fraction and liver stiffness measurement are promising predictors ...

Chronic HDV occurs only with HBV and confers markedly higher risks of rapid progression, cirrhosis, liver failure, and ...

Credit: istockphoto In a population-based Danish study, the 3-year risk for rapid progression of incident CKD stage G3 was nearly 15%. Men and those with certain conditions, such as diabetes, have ...

Please provide your email address to receive an email when new articles are posted on . The presence of clinical markers in patients with vitiligo may have an association with worsening prognoses and ...

Matrix metalloproteinases are a biologically plausible and promising biomarker for rapid disease progression in ADPKD and CKD in general. Matrix metalloproteinases may predict rapid disease ...

Summary: A collaborative neurobiology study uncovered a cellular mechanism tied to the severe, rapid progression of multiple sclerosis (MS). Published by a multidisciplinary team analyzing human ...

In a recent study published in the journal Nature Medicine, a large, international team of researchers conducted an exploratory analysis to evaluate whether the monoclonal antibody prasinezumab, which ...

Prasinezumab, a monoclonal antibody, is shown to reduce signs of motor deterioration in individuals with Parkinson's disease (PD) who have rapidly progressing disease, as reported in an exploratory ...

Phase I study combining pembrolizumab and aromatase inhibitor in patients with metastatic hormone receptor–positive breast cancer. Clinical outcomes with alpelisib (ALP) plus fulvestrant (FUL) after ...

A 53-year-old Chinese female diabetic with concurrent hypertension and ischaemic heart disease developed severe nonproliferative diabetic retinopathy (NPDR) and maculopathy in both eyes within 3 years ...

A new study suggests that the immune checkpoint inhibitor, durvalumab, may offer new treatment options for patients living with small cell lung cancer (SCLC). However, its cost raises questions about ...